|

JNJ-88998377 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Janssen Research & Development, LLC1

Indications

  • Relapsed B-cell NHL1
  • Refractory B-Cell NHL1
  • Lymphoma, Non-Hodgkin1
  • Cancer1

Other1 trial

A Study of JNJ-88998377 for Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.